Lara Davis
@DrLaraDavis
Followers
1K
Following
1K
Media
177
Statuses
2K
OHSU Knight Cancer Institute Sarcoma Program Director. Focused on bone sarcomas and sarcomas in adolescents & young adults (AYAs). #OHSUSarcoma
Portland, Oregon
Joined November 2009
What it’s like to be in healthcare right now: “We will pay you $2 for that pie” “But it costs me $4 in pie ingredients and $2 in human labor to make a pie. We need $6 to break even” “Sorry, we’ll only pay you $2 for that pie. We suggest you make many more pies that you also
177
526
3K
Dear Doctors, Happy annual cut-your-compensation day. This one comes with an additional demand for you to change your practice to address “whole body care” and spend lots of administrative overhead proving your “quality” with metrics that are mostly gamesmanship and complex
34
121
496
Hells yeah Massachusetts.
Not sure I have ever seen a billboard like this from a state or city health department. They are all over Western Mass now.
62
225
3K
As the sun sets on #asco24 I’d be remiss not to say that I’m worried about my colleagues I worry we are crushing one another with colossal expectations, with our emails & CVs You are more than your publications & presentations Please don’t tie your self-worth to brass rings
13
86
662
It is grossly irresponsible to say that these 5 unsupported claims mean the pandemic “probably” started with a lab leak. They misrepresent the actual evidence and put people like Dr. Fauci at great risk. The @nytopinion has shamed itself by printing untruths & outright lies.
5
219
1K
Powerhouse panel! @SARCtrials hosting a review of SARC028 data on #ICI in #sarcoma - followed by a cage fight / debate on TLS as a biomarker! Moderated by the unmatched @sandrapdangelo
0
7
21
Two #SARCtrials have been selected for oral presentation at #ASCO24. SARC032 and SARC037 will be presented Monday, June 3rd during the #sarcoma session from 3-6pm CDT. See more here: https://t.co/p5raKUzGZJ
#ASCO2024 #ASCO #clinicaltrial
sarctrials.org
SARC032 and SARC037 to be presented at ASCO 2024.
1
9
30
It was a blast writing a chapter on updated approaches to #MPNST #sarcoma with @carina_dehner, Dombi, Eulo, Gross, Lazar and lead @AngelaHirbe for the @ASCO education book. Check it out https://t.co/k9qkleiGZ1 and don’t miss the paired #ASCO2024 panel 5/31 4:30p S102! #ENDNF
ascopubs.org
Most malignant peripheral nerve sheath tumors (MPNSTs) are clinically aggressive high-grade sarcomas, arising in individuals with neurofibromatosis type 1 (NF1) at a significantly elevated estimated...
1
7
21
Dr. @coussens_lisa's work “led a shift in the way we think of cancer, from a bunch of cells in isolation to considering how the surrounding microenvironment around the tumors can be exploited to develop better anti-cancer therapies.” #WomensHistoryMonth:
1
6
17
💪 Crush Cancer 🗓️ May 18 ⏰ 8 am 📍 Faith Hope & Charity Vineyards Enjoy the gorgeous scenery during the "Crush Cancer" race and walk benefiting @OHSUKnight to support Central Oregon Families battling cancer and facing financial need:
faithhopeandcharityevents.com
Crush Cancer Event is a family-friendly event with 5k,10k, and Half-Marathon trails in the Terrebonne area hosted by Faith Hope & Charity Vineyards. Register for the event on our website today!
0
2
1
https://t.co/mUUVFZ6Iho ProPublica has done it again. These terrifying glimpses inside health insurance corporations are so important. People need to understand what we're up against. These corporations don't care about you. @Cigna
propublica.org
Cigna tracks every minute that its staff doctors spend deciding whether to pay for health care. Dr. Debby Day said her bosses cared more about being fast than being right: “Deny, deny, deny. That’s...
51
735
2K
I made a video. Please keep sharing. I need this to go viral for our case to the @US_FDA
CALL TO ACTION: I need all of your help. There is a black box warning on low dose vaginal estrogen (VE) products. See below. It states, "warning: endometrial cancer, cardiovascular disorders, probable dementia." Low dose VE has NEVER been show to cause any of the above.
26
724
2K
This. Thanks.
@sgremminger As a physician, would just ask that you give grace. The first patient may have had a new devastating diagnosis (leukemia, brain tumor) or was suicidal. The physician may have miscarried on the way to work, gotten a call that their own parent was in the ED, or needed to find last
0
0
3
The registrational enabling Spearhead-1 study shows that afami-cel, an engineered T cell targeting MAGEA4, has promising efficacy in synovial sarcoma and MRCLS paving the way for T cell therapy in solid tumors. @MSKCancerCenter @MSK_DeptOfMed @MSKSarcoma
https://t.co/P8NamCL3bg
3
32
89
More from Dr. Shivaani Kummar on treatment options for desmoid tumors ⤵️ #RareDiseaseDay2024
“Seeing the responses and clinical benefit reported in the Phase I trial, I felt that we should further evaluate this new drug for its likelihood to benefit patients with this rare tumor.” - Dr. Shivaani Kummar on treatment options for desmoid tumors:
0
2
2
"Desmoid tumors can result in significant impact on functioning and quality of life of patients." - Dr. Shivaani Kummar, who conducted the Phase 2 clinical trial study for the drug nirogacestat (a treatment of desmoid tumors):
0
2
5
Wow! Yes!
Sharing this for all women! And specially for my #WomeninMedicine Found it on social media- not sure who to credit/cite but definitely needed to see it today! 🤗
0
0
3
✅Improved overall survival ✅Improved compliance to clinical practice guidelines ✅📈 pre-surgery biopsies ✅📈 pre-surgery presentation at the NETSARC MDTB ✅📈 R0 resection on first surgery ✅📉R2 resection 2/2
0
5
5